ABEONA THERAPEUTICS INC. (ABEO) Cash Flow Statement
ABEONA THERAPEUTICS INC. (ABEO) generated -$76.4M of operating cash flow over the twelve months to 2026-06-30, spent $5.1M on capital expenditure and had free cash flow of -$81.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ABEOABEONA THERAPEUTICS INC.Follow ABEO — free
—
Price chart with a free account
- Market cap
- 251.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -7.6 | -4.0 | 0.0 | -1.6 | -10.4 | -13.0 | -22.7 | -39.1 | -35.0 | -65.7 | -43.5 | -37.0 | -76.3 | -76.4 | |
| Capital expenditure | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.5 | 0.9 | 9.2 | 1.3 | 4.2 | 0.1 | 0.3 | 8.0 | -5.1 | |
| Free cash flow | -7.6 | -4.0 | -0.0 | -1.6 | -10.7 | -13.5 | -23.5 | -48.4 | -36.4 | -69.8 | -43.6 | -37.3 | -84.3 | -81.5 | |
| Stock-based compensation | 1.1 | 0.4 | 0.4 | 1.3 | 4.4 | — | — | — | — | — | 3.1 | 4.8 | 10.8 | — |
USD millions · SEC XBRL
ABEONA THERAPEUTICS INC. — questions
- What is ABEONA THERAPEUTICS INC.'s operating cash flow?
- -$76.4M over the twelve months to 2026-06-30.
- How much does ABEONA THERAPEUTICS INC. spend on capital expenditure?
- $5.1M over the twelve months to 2026-06-30.
- What is ABEONA THERAPEUTICS INC.'s free cash flow?
- -$81.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from ABEONA THERAPEUTICS INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.